Company Profile
Updated: 24-SEP-09Enzo Biochem Inc.
Exporter
527 Madison Ave., New York, NY 10022-4304, United States
(212)583-0100, http://www.enzo.com
Primary SIC: Medical Laboratories, Primary NAICS: Medical Laboratories
Description: Enzo Biochem Inc. was founded in 1976 and is publicly traded on the New York Stock Exchange. It is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics; and on serving as a provider of diagnostic services to the medical community. Enzo Biochem operates through three business segments: Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs. Enzo Life Sciences manufactures, develops and markets biomedical research products and tools to research and pharmaceutical customers worldwide and has amassed a large patent and technology portfolio. Enzo Therapeutics is a biopharmaceutical company that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases. Enzo Clinical Labs is a regional clinical laboratory to the New York Metropolitan and New Jersey areas, which offers routine and esoteric clinical laboratory tests or procedures used by physicians in general patient care. Enzo Biochem operates a full-service clinical laboratory in Farmingdale, N.Y., a network of 23 patient service centers, a stand alone "stat" or rapid response laboratory in New York City, a full-service phlebotomy department and has its company headquarters in New York City. More
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Enzo Biochem Executive Says Oral Immune Regulation Platform Shows "Therapeutic Promise".
Biotech Week; 11/18/2009; 842 words; Enzo Biochem, Inc. (NYSE:ENZ) reported on the Company's therapeutic...Biochem, Immune-mediated Disease, Therapy, Treatment, Enzo Biochem Inc (see also Enzo Biochem, Inc.). This article was prepared by Biotech Week editors...
Enzo Biochem Reports on Favorable Clinical Trial of EGS21 for Treatment of Non-Alcoholic Steatohepatitis.(Clinical report)
Hepatitis Weekly; 11/16/2009; 1206 words; Enzo Biochem Inc. (NYSE:ENZ) announced that favorable results of the Company...patients with NASH and its associated metabolic syndrome (see also Enzo Biochem Inc.). Enzo scientists and collaborators presented data showing that "oral...
News and FDA Updates for SunLink (NYSE:SSY), Enzo Biochem Inc. (NYSE:ENZ), Pro-Pharmaceuticals (OTC:PRWP).
M2 Presswire; 11/16/2009; 1062 words; ...Updates for SunLink (NYSE:SSY), Enzo Biochem Inc. (NYSE:ENZ), Pro-Pharmaceuticals...09, SunLink Health Systems, Inc. (NYSE:SSY) announced earnings...September 30, 2008. On 13/11/09, Enzo Biochem Inc. (NYSE:ENZ) announced David...
Enzo Biochem Executive to Discuss Oral Immune Regulation Platform at Windhover TA Partnerships 2009 Conference.(Conference news)(Clinical report)
Business Wire; 11/13/2009; 1157 words; EGS21, Enzo's Orally Administered Glucosylceramide...Projects to Watch at Meeting NEW YORK -- Enzo Biochem Inc. (NYSE:ENZ) announced today that...Wednesday, November 18, 2009, where Enzo's EGS21, an orally administered beta...
News and FDA Updates for Bruker (NASDAQ:BRKR), ImmunoGen (Nasdaq:IMGN), Enzo (NYSE:ENZ).
M2 Presswire; 11/12/2009; 1015 words; ...ImmunoGen (Nasdaq:IMGN), Enzo (NYSE:ENZ)(C)1994-2009...City. On 11/11/09, ImmunoGen, Inc. (Nasdaq:IMGN), a biotechnology...Shareholders. On 11/11/09, Enzo Biochem, Inc. (NYSE:ENZ), a leading vertically...
Services: Diagnostic laboratory. Manufacturing: Manufactures biomedical products for diagnostic and research use.
Recent News Articles
- News and FDA Updates for SunLink (NYSE:SSY), Enzo Biochem Inc. (NYSE:ENZ), Pro-Pharmaceuticals (OTC:PRWP).
M2 Presswire - November 16, 2009 - HearAtLast Holdings, Inc. & Enzo Biochem, Inc.
M2 Presswire - November 04, 2009 - ENZO BIOCHEM, INC - Financial and Strategic Analysis Review.
M2 Presswire - May 03, 2009 - Enzo 2nd qtr loss 88% deeper on various costs.(Enzo Biochem Inc.)(Financial report)(Brief article)
Pharma Marketletter - March 30, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning